BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31199317)

  • 1. Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study.
    Smit M; van Pelt G; Roodvoets A; Meershoek-Klein Kranenbarg E; Putter H; Tollenaar R; van Krieken JH; Mesker W
    JMIR Res Protoc; 2019 Jun; 8(6):e13464. PubMed ID: 31199317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study.
    Smit MA; van Pelt GW; Dequeker EM; Al Dieri R; Tollenaar RA; van Krieken JHJ; Mesker WE;
    JMIR Form Res; 2021 Mar; 5(3):e19408. PubMed ID: 33739293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
    Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
    ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance.
    Strous MTA; Faes TKE; Gubbels ALHM; van der Linden RLA; Mesker WE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; Vogelaar FJ; de Bruïne AP
    Clin Transl Oncol; 2022 Jun; 24(6):1047-1058. PubMed ID: 35064453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
    Smit MA; van Pelt GW; Terpstra V; Putter H; Tollenaar RAEM; Mesker WE; van Krieken JHJM
    Int J Colorectal Dis; 2021 Dec; 36(12):2729-2737. PubMed ID: 34533595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of the Tumor-Stromal Ratio in Invasive Breast Cancer and a Proposal of a New Ts-TNM Staging System.
    Xu Q; Yuan JP; Chen YY; Zhang HY; Wang LW; Xiong B
    J Oncol; 2020; 2020():9050631. PubMed ID: 32377197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study.
    Smit MA; Philipsen MW; Postmus PE; Putter H; Tollenaar RA; Cohen D; Mesker WE
    Cancer Treat Res Commun; 2020; 25():100247. PubMed ID: 33249210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancer.
    van Wagensveld L; Walker C; Hahn K; Sanders J; Kruitwagen R; van der Aa M; Sonke G; Rottenberg S; Van de Vijver K; Janowczyk A; Horlings H
    Res Sq; 2023 Nov; ():. PubMed ID: 38014112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized Assessment of the Tumor-Stroma Ratio in Colorectal Cancer: Interobserver Validation and Reproducibility of a Potential Prognostic Factor.
    Souza da Silva RM; Queiroga EM; Paz AR; Neves FFP; Cunha KS; Dias EP
    Clin Pathol; 2021; 14():2632010X21989686. PubMed ID: 33634262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-stroma ratio predicts recurrence in patients with colon cancer treated with neoadjuvant chemotherapy.
    Hansen TF; Kjær-Frifeldt S; Lindebjerg J; Rafaelsen SR; Jensen LH; Jakobsen A; Sørensen FB
    Acta Oncol; 2018 Apr; 57(4):528-533. PubMed ID: 28980848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
    Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
    Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal of an automated tumor-stromal ratio assessment algorithm and a nomogram for prognosis in early-stage invasive breast cancer.
    Xu Q; Chen YY; Luo YH; Zheng JS; Lin ZH; Xiong B; Wang LW
    Cancer Med; 2023 Jan; 12(1):131-145. PubMed ID: 35689454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep learning based tumor-stroma ratio scoring in colon cancer correlates with microscopic assessment.
    Smit MA; Ciompi F; Bokhorst JM; van Pelt GW; Geessink OGF; Putter H; Tollenaar RAEM; van Krieken JHJM; Mesker WE; van der Laak JAWM
    J Pathol Inform; 2023; 14():100191. PubMed ID: 36794267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.
    Schraa SJ; van Rooijen KL; van der Kruijssen DEW; Rubio Alarcón C; Phallen J; Sausen M; Simmons J; Coupé VMH; van Grevenstein WMU; Elias S; Verkooijen HM; Laclé MM; Bosch LJW; van den Broek D; Meijer GA; Velculescu VE; Fijneman RJA; Vink GR; Koopman M;
    BMC Cancer; 2020 Aug; 20(1):790. PubMed ID: 32819390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
    Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
    Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.
    Zhao K; Li Z; Yao S; Wang Y; Wu X; Xu Z; Wu L; Huang Y; Liang C; Liu Z
    EBioMedicine; 2020 Nov; 61():103054. PubMed ID: 33039706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
    Zheng Q; Jiang Z; Ni X; Yang S; Jiao P; Wu J; Xiong L; Yuan J; Wang J; Jian J; Wang L; Yang R; Chen Z; Liu X
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.